General. Chemicals and solvents were purchased from Fisher Scientific and used as received.
Deuterated solvents were purchased from Cambridge Isotope Laboratories (Cambridge, MA).
Molecular weights were determined using gel permeation chromatography (GPC) against polystyrene standards on a Shimadzu high performance liquid chromatography (HPLC) system equipped with PLgel 5 μm MIXED-D columns and SPD-20A ultraviolet-visible (UV-vis) detector a flow rate of 1.0 mL/min. UV-Vis spectra were recorded using Varian Cary 50 Bio spectrophotometer. Fluorescence spectra were obtained using a FluoroLog-3 Spectrofluorometer (Jobin Yvon/Horiba). Quantum yields (QYs) were determined using 9,10-diphenylanthracene (QY= 0.9) in cyclohexane as a fluorescence standard. Fourier transform infrared (FT-IR) spectra were recorded on a PerkinElmer Spectrum 100 FT-IR Spectrometer. Fine powders from lyophilized samples were directly mounted on an attenuated total reflection (ATR) cell of the spectrometer. The purification of the CPNs was conducted using an Ultrafiltration Stirred Cell (Millipore) with a 10 kDa molecular weight cut-off (MWCO) membrane (Ultracel ultrafiltration disc). Nuclear magnetic resonance (NMR) spectra for the conjugated polymers (CPs) were recorded on a 400 MHz Avance Bruker NMR spectrometer.
Chemical shifts were reported in parts per million (ppm) for 1 H NMR on the δ scale based on the middle peak (δ = 2.50 ppm) of the dimethylsulfoxide (DMSO)-d 6 solvent as an internal standard.
NMR spectra for the conjugated polymer nanoparticles (CPNs) were recorded on a 600 MHz Electronic Supplementary Material (ESI) for ChemComm. This journal is © The Royal Society of Chemistry 2015
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Avance Bruker NMR spectrometer using a 5 mm BBI probe at 298 K. The 600 MHz NMR spectrometer is equipped with a gradient system capable of producing magnetic field pulse gradients in the z-direction of about 50 G cm -1 and allowing for water peak suppression [δ = 4.79 ppm in deuterium oxide (D 2 O)]. Chemical shifts were reported in parts per million (ppm) for 1 H NMR on the δ scale based on the middle peak (δ = 4.79 ppm) of D 2 O solvent as an internal standard. Graphs were plotted using Origin 9.1 software (OriginLab, Northampton, MA, USA).
Polymer synthesis.
General procedure. A Schlenk flask was charged with aryl halide monomer (1.0 equiv) and diacetylene monomer (1.0 equiv for P2, 0.9 equiv for P3), and cystine linker when applicable (0.1 equiv for P3) along with Pd[(PPh 3 ) 2 Cl 2 ] (0.1 equiv) and CuI (0.05 equiv). The Schlenk flask was evacuated and filled with N 2 three times. A solution of anhydrous dimethylformamide (DMF) (3 mL) and morpholine (1 mL) was degassed, and 2 mL of the mixed solution was transferred to the Schlenk flask using a cannular needle. The reaction mixture was heated at 50 °C for 18 h. The solution was then cooled to room temperature and transferred dropwise to cold ethyl ether, resulting in precipitation. After centrifugation (5 min, 4000 rpm), the supernatant was decanted, and the precipitate was redissolved in DMF (1 mL). The resulting polymer was characterized using GPC by diluting an aliquot of polymer solution in 1 mL of HPLC grade tetrahydrofuran (THF) and filtered through 0.45 μm polytetrafluoroethylene (PTFE) syringe filter prior to injection. The absorption and emission profiles were measured in a 10 mm quartz cuvette (2 mL) using a diluted aliquot of the polymer solution in DMF. The material was then reprecipitated in pure ether, the supernatant was decanted, and the precipitate was purified two S-3 more times. The precipitated polymer was allowed to dry under high vacuum for 4 hours prior to FT-IR and 1 H NMR characterization.
CPN fabrication. Boc-deprotection of the polymer was carried out by adding the polymer solution in DMSO-d 6 to a stirred mixture of trifluoroacetic acid (2 mL) and acetic acid (2 mL) and allowed to stir at room temperature for 2 days. The mixture was then diluted by addition of acetic acid (10 mL), and added dropwise (2 drops/s) to 500 mL water (18 Ω) while stirring.
Using a solvent-resistant stir cell fitted with a 10 kDa-MWCO membrane, the solution was concentrated to approximately 10 mL, and dialyzed against 2 L of water. The solution was subsequently filtered through a cellulose syringe filter (0.45 µm), characterized, and stored for future use.
P1:
Detailed monomer and polymer synthesis, CPN fabrication and characterization is described elsewhere. 1
P2:
Detailed monomer synthesis and characterization of monomers A and B1 is described elsewhere. 1,2 Using the general procedure described above, the polymerization of monomer A 
P3:
Detailed monomer synthesis and characterization of monomers B2 and C is described elsewhere. 1,2 Using the general procedure described above, the polymerization of monomer A 
P4:
Detailed monomer and polymer synthesis, CPN fabrication and characterization is described elsewhere. 1, 3 CPN/GAG complexation. Sodium hyaluronate (HA) was purchased from Lifecore (MW 100 K) and used as received. A stock solution was prepared by dissolving 2.0 mg of HA in 1 mL of deionized water. Heparin sodium was purchased from Acros Organics and used as received. A stock solution was prepared by dissolving 4.0 mg of HS in 1 mL of deionized water. Chondroitin sulfate A (CS) and chondroitin sulfate B (dermatan sulfate, DS) were purchased from Sigma Aldrich and used as received. Stock solutions of CS and DS were prepared by dissolving 2.0 mg and 1.0 mg, respectively, in 1 mL of deionized water. CPN and GAG were mixed and allowed to incubate for 30 minutes prior to measurements. For consistency between the CPNs, the concentration was adjusted to give an optical density of 0.1, which corresponds to approximately 10 μM (based on polymer repeating unit). The GAG concentration used was 30 μM (based on GAG repeating unit). Samples were prepared in deionized water, unless otherwise stated.
Determination of hydrodynamic diameters of CPNs. Light scattering measurements were performed with a LM10 HS (NanoSight, Amesbury, United Kingdom), equipped with a sCMOS camera, sample chamber with a 488 nm blue laser, and Viton fluoroelastomer o-ring. The samples were prepared in similar manner for absorption and emission measurements using water (18 Ω) filtered through 0.45 μm PTFE syringe filters. The samples were injected into the sample chamber with 1 mL sterile syringes (Restek Corporation, Pennsylvania, USA) until the liquid S-7 reached the tip of the nozzle. All measurements were performed at 25°C using a LM14C temperature controller (NanoSight, Amesbury, United Kingdom). Each sample was measured three times.
Determination of zeta potentials of CPNs. Dynamic light scattering measurements were performed by Zetasizer nano-ZS (Zen 3600, Malvern Instruments Ltd.) using a folded capillary cell (Catalog # DTS1060), at room temperature. The samples were prepared at approximately 0.5 mM in water (18 Ω), which was filtered through 0.45 μM PTFE syringe filter. Each sample was measured six times.
Hierarchical cluster analysis (HCA) of emission spectra. The commercially available statistical software JMP ® (version 11) was used for analysis. For simplicity, one CPN emission data set in water (triplicate samples) was used for HCA to demonstrate role of functional group in differentiation. The default distance calculation method, Ward's, was used for cluster distances.
CPN in synthetic urine. Surine TM was purchased from Dyna-Tek Industries, Inc. (product #720) and used as received. Surine TM is a urine simulant, with a proprietary formula, which contains creatinine and urea, and was used as media for CPN/GAG measurements. For the differentiation application and to simulate detection of GAGs present in urine, GAGs (100 nM) were mixed in Surine TM , then CPN was added to the GAG-containing urine simulant and allowed to incubate for 30 minutes prior to measurements.
LDA of emission spectra. The commercially available statistical software JMP ® (version 11) was used for analysis. The data included in the training matrix were the emission spectra ratios of CPN to CPN+GAG in urine simulant. The matrix training set was 4 CPNs x 4 GAGs x 3
S-8
replicates, an input of 48 data sets (spectrum ratios). The discrimination method used was the linear, common covariance method. Fig. S-1 Chemical structures of glycosaminoglycans. 
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